Logotype for Alkem Laboratories Limited

Alkem Laboratories (ALKEM) investor relations material

Alkem Laboratories Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Alkem Laboratories Limited
Q1 25/26 earnings summary12 Aug, 2025

Executive summary

  • Achieved strong start to FY26 with 11.2% revenue growth year-over-year, driven by disciplined execution and robust domestic and international performance.

  • EBITDA grew 21.4%–21.9% year-over-year, with margin expansion to 21.9%.

  • PAT after minority interest rose 21.8% year-over-year to over ₹6,600 million, with PAT margin improving to 19.7%.

  • Outperformed the Indian Pharmaceutical Market (IPM) by 120 bps in domestic business growth and exceeded IPM in seven key therapies.

  • Board approved unaudited financial results for the quarter, with auditors issuing unmodified review reports.

Financial highlights

  • Total consolidated revenue from operations reached ₹33,711 million, up 11.2% year-over-year.

  • EBITDA increased to ₹7,039–7,391 million, with margin at 21.9%.

  • Net profit after minority interest was ₹6,602–6,679 million, up 21.8% year-over-year.

  • EPS grew 21.8% year-over-year to ₹55.6.

  • R&D expenses for the quarter were ₹1,184 million (3.5% of revenue).

Outlook and guidance

  • Management maintains FY26 guidance, with strong Q1 but will observe further quarters before any revision.

  • R&D expenses expected at 4.5–5% of revenue for the year, with higher spend in later quarters.

  • Gross margin guidance maintained at 64% for the full year; Q1 and Q2 typically stronger.

  • Operating margin guidance remains at 19.5% for FY26, with potential for upward revision.

  • Transfer of Generic Business Undertaking to a subsidiary expected to complete by October 1, 2025.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Alkem Laboratories earnings date

Logotype for Alkem Laboratories Limited
Q2 202611 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Alkem Laboratories earnings date

Logotype for Alkem Laboratories Limited
Q2 202611 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Alkem Laboratories Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded medicines. The company’s product portfolio spans multiple therapeutic areas, including anti-infectives, gastroenterology, cardiology, neurology, and pain management. It operates a network of research and manufacturing facilities to supply domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage